Company Jeil Pharma Holdings Inc

Company Jeil Pharma Holdings Inc

A002620

KR7002620003

Pharmaceuticals

Equities

A002620

KR7002620003

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
10,670 ^KRW	-1.57%		-3.87%	-9.35%

2023	Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.	CI

JEIL PHARMA HOLDINGS INC., formerly Jeil Pharmaceutical Co.,Ltd is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, anticancer drugs, tristimania drugs, gastritis drugs, stomach ulcer drugs, septicemia treatments, pollakisuria treatments, acute bronchitis remedies, hyperlipidemia treatments and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 39

KRW in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 101.8 %	812,943	102.5 %	818,400	101.8 %	+0.67%
Consolidated Adjustment -3.5 %	-31,592	-4.0 %	-28,044	-3.5 %	-11.23%
Investment 1.7 %	11,614	1.5 %	13,687	1.7 %	+17.86%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 96.7 %	786,912	99.2 %	777,165	96.7 %	-1.24%
Overseas 6.8 %	37,644	4.7 %	54,922	6.8 %	+45.90%
Consolidated Adjustment -3.5 %	-31,592	-4.0 %	-28,044	-3.5 %	-11.23%

Managers	Title	Age	Since
Sang-Cheol Han CEO	Chief Executive Officer	48	-
Bong-Hui Moon BRD	Director/Board Member	72	-
Jae-Hyeon Kim PRN	Corporate Officer/Principal	53	-

Members of the board	Title	Age	Since
Sang-Cheol Han CEO	Chief Executive Officer	48	-
Bong-Hui Moon BRD	Director/Board Member	72	-
Dong-Yeol Lee BRD	Director/Board Member	62	23/21/23
Byeong-Goo Seo BRD	Director/Board Member	57	-
Ki-Bong Park BRD	Director/Board Member	61	23/21/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,973,355	2,167,592 ( 13.57 %)	622,230 ( 3.895 %)	13.57 %

Name	Equities	%	Valuation
Seung-Soo Han 57.80 %	9,231,968	57.80 %	71 M ₩
Sang-Cheol Han 9.699 %	1,549,302	9.699 %	12 M ₩
OTSUKA HOLDINGS CO., LTD. 9.372 %	1,497,050	9.372 %	11 M ₩
JEIL PHARMA HOLDINGS INC 3.895 %	622,230	3.895 %	5 M ₩
Sang-woo Han 2.854 %	455,943	2.854 %	3 M ₩
Eung-soo Han 1.880 %	300,372	1.880 %	2 M ₩
Joo-hye Lee 0.6536 %	104,400	0.6536 %	797 673 ₩
Yi-young Min 0.1789 %	28,580	0.1789 %	218 367 ₩
Korea Investment Management Co., Ltd. 0.000351 %	56	0.000351 %	428 ₩

Name	Equities	%	Valuation
JEIL PHARMA HOLDINGS INC 3.90%	622,230	3.90%	4,754,179 $

JEIL PHARMA HOLDINGS, Inc.

343 Sapyeong-daero Seocho-gu

06543, Seoul

address Jeil Pharma Holdings Inc(A002620)

	1st Jan change	Capi.
JEIL PHARMA HOLDINGS INC	-9.35%	12Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	4.44TCr
OTSUKA HOLDINGS CO., LTD.	+24.60%	2.3TCr
SANDOZ GROUP AG	+18.88%	1.51TCr
CIPLA LIMITED	+12.87%	1.31TCr
ZYDUS LIFESCIENCES LIMITED	+44.67%	1.19TCr
ONO PHARMACEUTICAL CO., LTD.	-8.33%	698.92Cr
THE MEDICINES COMPANY	-0.05%	678.76Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	551.54Cr

Generic Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals